Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
NCT07087080
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
350
Enrollment
OTHER
Sponsor class
Conditions
Solitary Pulmonary Nodules
Lung Cancer
Interventions
OTHER:
Blood sampling
Sponsor
Hasselt University
Collaborators
[object Object]